Tildrakizumab signals safe for pregnant psoriasis patientsFebruary 7, 2020PsoriasisPsoriatic Arthritis
Psoriasis: A look back over the past 50 years, and forward to next stepsJanuary 29, 2020PsoriasisPsoriatic Arthritis
Registry data reveal temporal relationship between psoriasis symptoms and PsA onsetJanuary 29, 2020Psoriatic ArthritisPsoriasis
Apremilast more likely to succeed with moderate psoriatic arthritis activityJanuary 22, 2020Psoriatic Arthritis
Meta-analysis provides safety data on IL-17, IL-23 inhibitorsJanuary 2, 2020PsoriasisPsoriatic Arthritis
Ultrasound improves specificity of psoriatic arthritis referralsDecember 19, 2019PsoriasisPsoriatic Arthritis
Evidence builds for effects of obesity, low physical activity on development of psoriatic arthritisDecember 12, 2019Psoriatic Arthritis
Repeat LTBI testing best in patients taking biologics with new risk factorsDecember 9, 2019Psoriatic ArthritisInfectious DiseasesPsoriasis
Certolizumab safety profile varies widely across indicationsNovember 27, 2019PsoriasisPsoriatic Arthritis
SPIRIT-H2H results confirm superiority of ixekizumab over adalimumab for PsANovember 21, 2019Psoriatic ArthritisPsoriasis
FDA announces approval of fifth adalimumab biosimilar, AbriladaNovember 18, 2019Psoriatic ArthritisPsoriasis
Expert shares tips for TNF-alpha inhibitor use in special populationsNovember 12, 2019PsoriasisPsoriatic Arthritis
